Latest articles
Calm, cited readings of material exchange filings. Cited, not tips.
Sort:Newest
Sector:Healthcare
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 2 Oct · 1 min
Aurobindo's Apitoria Closes Acquisition of A1 Biochem's Contract Research Business
Wholly owned subsidiary Apitoria Pharma has completed its purchase, taking an 80% stake in A1 Biochem Labs (India) and, through it, the group's US operations.
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 2 Oct · 1 min
Aurobindo arm completes US acquisition of A1 Biochem Labs for USD 15.25 million
A1 Biochem USA Inc has acquired 100% of A1 Biochem Labs LLC, a North Carolina contract research and chemistry services firm, in an all-cash deal completed on October 2, 2026.
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 1 Oct · 1 min
A1 Biochem Labs no longer wholly owned as former promoter takes 20%
Aurobindo's step-down subsidiary A1 Labs allotted shares and debentures to former promoter Dr. Rajendra Gadikota, leaving Apitoria with 80%.
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · NSE · Filed 23 Sept · 1 min
Jagsonpal to acquire Group Pharmaceuticals' Wellness Portfolio via slump sale
The company signed a Business Transfer Agreement to buy the women's-health portfolio on a going-concern basis, with consideration capped at ₹46.7 crore.
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 12 Sept · 1 min
Aurobindo Subscribes USD 1 Million to Fully Own New US Research Arm
An Aurobindo step-down subsidiary has fully subscribed the initial share capital of A1 Biochem USA Inc, a newly incorporated US contract research and development company.
SUNPHARMA · Sun Pharmaceutical Industries Limited · NSE · Filed 24 Jul · 1 min
Organon Stockholders Approve Sun Pharma's Proposed Acquisition
Sun Pharma says Organon stockholders have approved the merger under which Organon would become a wholly owned subsidiary of a Sun Pharma unit.
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 23 Jul · 2 min
Aurobindo's Apitoria to buy 80% of A1 Biochem's contract-research business at USD 17 mn enterprise value
Aurobindo's wholly owned subsidiary Apitoria Pharma will take majority control of A1 Biochem, a US- and India-based contract research organisation, to build a CRDMO platform alongside its API manufacturing.
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · NSE · Filed 17 Jul · 1 min
Jagsonpal Completes Acquisition of 85% Stake in Aequitas Healthcare
The company told the exchanges it has closed its previously announced purchase of an 85% equity stake in Aequitas Healthcare Private Limited.
AUROPHARMA · Aurobindo Pharma Limited · BSE · Filed 10 Jul · 1 min
Aurobindo Pharma incorporates new manufacturing subsidiary in Indonesia
An Indonesian step-down arm has set up PT Auro Pharm Indonesia, a wholly owned entity formed to run manufacturing operations in the country.
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · NSE · Filed 7 Jul · 1 min
Jagsonpal Pharmaceuticals completes majority acquisition, makes Aequitas Healthcare a subsidiary
The company said it has completed the purchase of a 69.77% stake in Aequitas Healthcare Private Limited, part of a proposed 85% acquisition, making Aequitas its subsidiary.
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 30 Jun · 1 min
Aurobindo completes acquisition of US generics firm Lannett
Aurobindo Pharma USA has closed its purchase of Lannett Company, which will now operate as a wholly owned subsidiary after US regulatory clearance.
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · BSE · Filed 29 Jun · 1 min
Jagsonpal to Acquire 85% of Hospital Distributor Aequitas Healthcare for ₹20.8 Crore
The gynaecology-and-orthopaedics maker signed a Share Purchase Agreement for a majority stake in a Mumbai company that sells pharmaceutical products to hospitals, funded from internal accruals.
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · BSE · Filed 29 Jun · 1 min
Jagsonpal to acquire 85% of Aequitas Healthcare, entering the hospital segment
The pharma company will pay ₹20.8 crore from internal accruals for a controlling stake in Mumbai-based Aequitas Healthcare, marking its first move into hospital-channel sales.
AUROPHARMA · Aurobindo Pharma Limited · BSE · Filed 25 Jun · 1 min
Aurobindo Pharma takes 26% stake in Swarnaakshu Solar, signs captive solar power deal
The drugmaker made an initial Rs.52 lakh investment for a 26% stake in Swarnaakshu Solar Power and entered a power purchase agreement for captive solar power under Telangana's captive power policy.
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 22 Jun · 1 min
Aurobindo's US arm clears FTC hurdle to acquire Lannett, deal set to close by end-June
Aurobindo Pharma USA has received U.S. Federal Trade Commission approval to proceed with its $250 million acquisition of Pennsylvania-based generic maker Lannett Company.
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 19 Jun · 1 min
Aurobindo Pharma Clears US FTC Hurdle for Lannett Acquisition
Aurobindo's US subsidiary has obtained the required US Federal Trade Commission approval to acquire 100% of Lannett Company LLC, with closing anticipated before the end of June.